These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1619383)

  • 1. Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin.
    Linde T; Sandhagen B; Danielson BG; Wikström B
    J Intern Med; 1992 Jun; 231(6):601-6. PubMed ID: 1619383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca.
    Linde T; Ronquist G; Sandhagen B; Wikström B; Frithz G; Pettersson L; Danielson BG
    Nephron; 1994; 68(4):419-26. PubMed ID: 7870225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
    Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
    Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
    Landgraf H; Grützmacher P; Garcia-Bartels C; Bergmann M; Ehrly AM; Schoeppe W
    Eur J Med; 1993; 2(7):393-7. PubMed ID: 8258026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
    Delamaire M; Durand F; Hamel D; Joyeux V; Lepogamp P; Genetet B
    J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in rheology and red blood cell function under recombinant human erythropoietin therapy.
    Schmidt R; Lerche D; Dörp E; Winkler R; Klinkmann H
    Pol Arch Med Wewn; 1991 Jun; 85(6):384-90. PubMed ID: 1896402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheological studies during treatment of renal anaemia with recombinant human erythropoietin.
    Macdougall IC; Davies ME; Hutton RD; Coles GA; Williams JD
    Br J Haematol; 1991 Apr; 77(4):550-8. PubMed ID: 2025581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy.
    Lerche D; Schmidt R; Zoellner K; Meier W; Paulitschke M; Distler B; Klinkmann H
    Contrib Nephrol; 1989; 76():299-303; discussion 304-5. PubMed ID: 2684529
    [No Abstract]   [Full Text] [Related]  

  • 9. The required dose of erythropoietin during renal anaemia treatment is related to the degree of impairment in erythrocyte deformability.
    Linde T; Sandhagen B; Wikström B; Danielson BG
    Nephrol Dial Transplant; 1997 Nov; 12(11):2375-9. PubMed ID: 9394325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants.
    Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O
    Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased whole blood viscosity combined with decreased erythrocyte fluidity in untreated patients with essential hypertension.
    Sandhagen B; Frithz G; Waern U; Ronquist G
    J Intern Med; 1990 Dec; 228(6):623-6. PubMed ID: 2280239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration.
    Icardi A; Paoletti E; Traverso GB; Sarchi C; Cappelli G; Molinelli G
    Int J Artif Organs; 1991 Mar; 14(3):147-9. PubMed ID: 2045188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM; Heidland A
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemorheological changes in uraemic children in response to erythropoietin treatment.
    Böhler T; Leo A; Linderkamp O; Braun A; Schärer K
    Nephrol Dial Transplant; 1993; 8(2):140-5. PubMed ID: 8384334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity.
    Shand BI; Buttimore AL; Lynn KL; Bailey RR; Robson RA
    Ren Fail; 1994; 16(3):407-13. PubMed ID: 8059023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
    Baldamus CA; Steffen AM; Brunner R; Pollok M
    Contrib Nephrol; 1990; 82():79-85. PubMed ID: 2093531
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term effects of rhEPO therapy on erythrocyte rheology in dialysis patients with different target hematocrits.
    Paulitschke M; Ludat K; Riedel E; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S36-41. PubMed ID: 10746804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of recombinant human erythropoietin in predialysis patients.
    Besarab A; Ross RP; Nasca TJ
    Curr Opin Nephrol Hypertens; 1995 Mar; 4(2):155-61. PubMed ID: 7600046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.